Alivus Life Sciences Limited (BOM:543322)
India
· Delayed Price · Currency is INR 1,008.60
-36.85 (-3.52%)
At close: Apr 28, 2026
Alivus Life Sciences Revenue
Alivus Life Sciences had revenue of 6.73B INR in the quarter ending December 31, 2025, with 4.84% growth. This brings the company's revenue in the last twelve months to 25.12B, up 10.48% year-over-year. In the fiscal year ending March 31, 2025, Alivus Life Sciences had annual revenue of 23.87B with 4.54% growth.
Revenue (ttm)
25.12B
Revenue Growth
+10.48%
P/S Ratio
4.92
Revenue / Employee
11.40M
Employees
2,203
Market Cap
123.68B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neuland Laboratories | 15.75B |
| Shilpa Medicare | 14.33B |
| Suven Life Sciences | 70.62M |
| Gujarat Themis Biosyn | 1.59B |
| IOL Chemicals and Pharmaceuticals | 22.27B |
| Sai Parenteral's | 1.63B |
| NGL Fine-Chem | 4.47B |
| Bajaj HealthCare | 6.12B |